Perspective Therapeutics (CATX) Return on Sales (2010 - 2023)

Perspective Therapeutics (CATX) posted Return on Sales of 0.01% for Q4 2023, up 394.67% sequentially from 0.0% in Q3 2023.

Perspective Therapeutics (CATX) Return on Sales (2010 - 2023) Analysis & Trends

Perspective Therapeutics has reported Return on Sales for 14 years, with the latest figure at 0.01% in Q4 2023.

Quarterly Return on Sales changed N/A year-over-year to 0.01% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.11% (changed N/A YoY) and the FY2023 annual result came in at 0.06%, changed N/A from the prior year.
Return on Sales grew to 0.01% in Q4 2023 per CATX's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 0.01% in Q1 2021.
A 5-year average of 0.01% and a median of 0.01% in 2019 frame the typical range for Return on Sales.
The sharpest annual moves came in 2019 and 2021: Return on Sales rose 1 bps in 2019, then decreased 1 bps in 2021.
Over 5 years, Return on Sales stood at 0.01% in 2019, then increased by 19 bps to 0.0% in 2020, then declined by 19 bps to 0.01% in 2021, then plunged by 84 bps to 0.01% in 2022, then surged by 201 bps to 0.01% in 2023.
According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 0.0%, and 0.01% for Q4 2023, Q3 2023, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.00%
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	0.00%
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.00%
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.00%
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.00%
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	0.00%
10	Perspective Therapeutics	388.50 Mn	388.50 Mn	-	-

Download Data